Standard Operating Procedures for Peyronie's Disease

Journal of Sexual Medicine

Volumn 10, Issue 1, 2013, Pages 230-244

  Levine, Laurence A ^a   Burnett, Arthur L ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Penile Prosthesis; Peyronie's Disease; Plaque Incision or Excision with Grafting; Plication Procedures; Surgical Straightening of Penis

Indexed keywords

ALPHA TOCOPHEROL; AMINOBENZOIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CARNITINE; COLCHICINE; COLLAGENASE; CORTICOSTEROID; INTERFERON; PAPAVERINE; PENTOXIFYLLINE; PHENTOLAMINE; PROSTAGLANDIN E1; TAMOXIFEN;

ARTICLE; CONSERVATIVE TREATMENT; CORPORA CAVERNOSA; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; EXTERNAL ENERGY THERAPY; HUMAN; IONTOPHORESIS; MEDICAL DEVICE; PATHOPHYSIOLOGY; PENILE TRACTION DEVICE; PENIS; PEYRONIE DISEASE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOTHERAPY; SEXUAL FUNCTION; STANDARD OPERATING PROCEDURE; THERAPY; TUNICA ALBUGINEA;

EID: 84872871414     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.03003.x     Document Type: Article

References (106)

1. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: Results of a large survey. BJU Int 2001;88:727-30.
2. Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, Davis R, Hellstrom W. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 2004;171:2350-3.
3. Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S. A retrospective review of 307 men with Peyronie's disease. J Urol 2002;168:1075-9.
4. Van de Water L. Mechanisms by which fibrin and fibronectin appear in healing wounds: Implications for Peyronies's disease. J Urol 1997;157:306-10.
5. Levine LA, Greenfield JM. Establishing a standardized evaluation of the man with Peyronies's disease. Int J Impot Res 2003;15(suppl 5):S103-12.
6. Hellstrom WJG, Feldman R, Smith T, Kaufman G, Tursi J. Phase 3 Study of CCH in Patients with Peyronie's disease: Development and validation of the Peyronie's Disease Questionnaire (PDQ). Presented at the 2012 annual Meeting of the American Urological Society, Atlanta, GA. Abstract #1690. 2012.
7. Nelson CJ, Diblasio C, Kendirci M, Hellstrom W, Guhring P, Mulhall JP. The chronology of depression and distress in men with Peyronie's disease. J Sex Med 2008;5:1985-90.
8. Rosen R, Catania J, Lue T, Althof S, Henne J, Hellstrom W, Levine L. Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controls. J Sex Med 2008;5:1977-84.
9. Bacal V, Rumohr J, Sturm R, Lipshultz LI, Schumacher M, Grober ED. Correlation of degree of penile curvature between patient estimates and objective measures among men with Peyronies's disease. J Sex Med 2009;6:862-5.
10. Benson JS, Abern MR, Levine LA. Penile shortening after radical prostatectomy and Peyronie's surgery. Curr Urol Rep 2009;10:468-74.
11. Wessells H, Lue T, McAninch J. Penile length in the flaccid and erect states: Guidelines for penile augmentation. J Urol 1996;156:995-7.
12. Moreno SA, Morgentaler A. Testosterone deficiency and Peyronie's disease: Pilot data suggesting a significant relationship. J Sex Med 2009;6:1729-35.
13. Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G. A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease. J Sex Med 2010;7(Pt 1):1529-37.
14. Ohebshalom M, Mulhall J, Guhring P, Parker M. Measurement of penile curvature in Peyronie's disease patients: Comparison of three methods. J Sex Med 2007;4:199-203.
15. Montorsi F, Guazzoni G, Bergamaschi F, Consonni P, Rigatti P, Pizzini G, Miani A. Vascular abnormalities in Peyronie's disease: The role of color Doppler sonography. J Urol 1994;15:373-5.
16. Lopez JA, Jarow JP. Penile vascular evaluation of men with Peyronie's disease. J Urol 1993;149:53-5.
17. Corder C, Levine LA, Rybak J. Calcified Peyronie's plaques: Prevalence, presentation and treatment selection. Proceedings from the 16th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America. Poster # 41. J Sex Med 2011;8(suppl 1):4-48.
18. Hellstrom WJ. Medical management of Peyronie's disease. J Androl 2009;30:397-405.
19. Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M, Levine L. The medical management of Peyronie's disease: Evidence-based 2010 guidelines. J Sex Med 2010;7:2359-74.
20. Larsen SM, Levine LA. Peyronie's disease: Review of nonsurgical treatment options. Urol Clin North Am 2011;38:195-205.
21. Schaeffer AJ, Burnett AL. Non-surgical interventions for Peyronie's disease: 2011 Update. J Androl 2012;33:3-14.
22. Pryor JP, Farell CF. Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol 1983;9:41-5.
23. Safarinejad MR, Hosseini SY, Kolahi AA. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: A double-blind, placebo-controlled, randomized study. J Urol 2007;178:1398-403.
24. Safarinejad MR. Therapeutic effects of colchicine in the management of Peyronie's disease: A randomized double-blind, placebo-controlled study. Int J Impot Res 2004;16:238-43.
25. Prieto Castro RM, Leva Vallejo ME, Regueiro Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU Int 2003;91:522-4.
26. Weidner W, Hauck EW, Schnitker J, Peyronie's Disease Study Group of Andrological Group of German Urologists. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: A perspective, placebo-controlled, randomized study. Eur Urol 2005;47:530-5.
27. Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999;162:2003-5.
28. Safarinejad MR, Asgari MA, Hosseini SY, Dadkhah F. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease. BJU Int 2010;106:240-8.
29. Valente EG, Vernet D, Ferrini MG, Qian A, Raijfer J, Gonzalez-Cadavid NF. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronies's fibrotic plaque and related fibroblast cultures. Nitric Oxide 2003;9:229-44.
30. Montorsi F, Corbin J, Phillips S. Review of phosphodiesterases in the urogenital system: New directions for therapeutic intervention. J Sex Med 2004;1:322-36.
31. Gelbard MK, James K, Riach P, Dorey F. Collagenase versus placebo in the treatment of Peyronie's disease: A double-blind study. J Urol 1993;149:56-8.
32. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: A prospective, single-center, non-placebo-controlled study. J Sex Med 2008;5:180-7.
33. Gelbard M, Lipshultz LI, Tursi J, Smith T, Kaufman G, Levine LA. Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie's disease. J Urol 2012;187:2268-74.
34. Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie's disease. J Urol 1994;151:1522-4.
35. Levine LA, Goldman K, Greenfield J. Experience with intraplaque injection of verapamil for Peyronie's disease. J Urol 2002;168:621-6.
36. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind study. Urology 1998;51:620-6.
37. Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie's disease. Urology 2007;69:1181-4.
38. Cavallini G, Modenini F, Vitali G. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease. Urology 2007;69:950-4.
39. Shirazi M, Haghpanah AR, Badiee M, Afrasiabi MA, Haghpanah S. Effect of intralesional verapamil for treatment of Peyronie's disease: A randomized single-blind, placebo-controlled study. Int Urol Nephrol 2009;41:467-71.
40. Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochiai A, Naitoh Y, Fujiwara T, Kamoi K, Miki T. Nicardipine vs. saline injection as treatment for Peyronie's disease: A prospective, randomized, single-blind trial. J Sex Med 2010;7:3743-9.
41. Hellstrom WJ, Kendirci M, Matern R, Cockerham Y, Myers L, Sikka SC, Venable D, Honig S, McCullough A, Hakim LS, Nehra A, Templeton LE, Pryor JL. Single-blind, multicenter, placebo-controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease. J Urol 2006;176:394-8.
42. Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O. Effect of intralesional interferon-alpha 2b with oral vitamin E for treatment of early stage Peyronie's disease: A randomized and prospective study. Urology 2006;67:1038-42.
43. Martin DJ, Badwan K, Parker M, Mulhall JP. Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol 2002;168:2483-5.
44. Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H. Iontophoresis for treatment of Peyronie's disease. J Urol 2000;163:95-9.
45. Di Stasi SM, Giannantoni A, Stephen RL, Capelli G, Giurioli A, Jannini EA, Vespasiani G. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. J Urol 2004;171:1605-8.
46. Greenfield JM, Shah SJ, Levine LA. Verapamil versus saline in electromotive drug administration for Peyronie's disease: A double-blind, placebo-controlled trial. J Urol 2007;177:972-5.
47. Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W. Extracorporeal shock wave therapy for Peyronie's disease: Exploratory meta-analysis of clinical trials. J Urol 2004;171:740-5.
48. Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. Eur Urol 2009;56:363-9.
49. Levine LA, Newell M, Taylor FL. Penile traction therapy for treatment of Peyronie's disease: A single-center pilot study. J Sex Med 2008;5:1468-73.
50. Gontero P, Di Marco M, Giubilei G, Bartoletti R, Pappagallo G, Tizzani A, Mondaini N. Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. J Sex Med 2009;6:558-66.
51. Fricke RE, Varney JH. Peyronie's disease and its treatment with radium. J Urol 1948;59:627-30.
52. Incrocci L, Wijnmaalen A, Slob AK, Hop WC, Levendag PC. Low-dose radiotherapy in 179 patients with Peyronie's disease: Treatment outcome and current sexual functioning. Int J Radiat Oncol Biol Phys 2000;47:1353-6.
53. Rybak J, Hehemann M, Corder C, Levine LA. Does Calcification of Peyronie's disease plaque predict progression to surgical correction? Presented at the 2012 Annual Meeting of the American Urological Association. May 2012, Atlanta, GA. 2012.
54. Jordan GH. Peyronie's disease. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh urology. Philadelphia, PA: Saunders Elsevier; 2007:818-38.
55. Taylor FL, Levine LA. Peyronie's disease. In: Seftel A, ed. Urologic clinics of North America. Philadelphia, PA: Elsevier; 2007:818-38. Urol Clin N Am 34(4):517-34.
56. Taylor FL, Levine LA. Surgical correction of Peyronie's disease via tunica albuginea plication or partial plaque excision with pericardial graft: Long-term follow-up. J Sex Med 2008;5:2221-8; discussion 2229-30.
57. Levine LA, Lenting EL. A surgical algorithm for the treatment of Peyronie's disease. J Urol 1997;158:2149-52.
58. Ralph DJ, Minhas S. The management of Peyronie's disease. BJU Int 2004;93:208-15.
59. Mulhall J, Anderson M, Parker M. A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction. Functional and satisfaction outcomes. J Sex Med 2005;2:132-8.
60. Taylor F, Abern M, Levine LA. Predicting erectile dysfunction following surgical correction of Peyronie's disease without inflatable penile prosthesis placement: Vascular assessment and preoperative risk factors. J Sex Med 2012;9:296-301.
61. Flores S, Choi J, Alex B, Mulhall JP. Erectile dysfunction after plaque incision and grafting: Short-term assessment of incidence and predictors. J Sex Med 2011;8:2031-7.
62. Andrews HO, al-Akraa M, Pryor JP, Ralph DJ. The Nesbit operation for congenital curvature of the penis. Int J Impot Res 1999;11:119-22.
63. Yachia D. Modified Corporoplasty for the treatment of penile curvature. J Urol 1990;143:80-2.
64. Gholami SS, Lue TF. Correction of penile curvature using the 16-dot plication technique: A review of 132 patients. J Urol 2002;167:2066-9.
65. Brant WO, Bella AJ, Lue TF. 16-dot procedure for penile curvature. J Sex Med 2007;2:277-80.
66. Baskin LS, Duckett JW. Dorsal tunica albuginea plication for hypospadius curvature. J Urol 1994;151:1668-71.
67. Levine LA. Penile straightening with tunica albuginea plication procedure: TAP procedure. In: Levine LA, ed. Peyronie's disease: A guide to clinical management. Totowa, NJ: Humana; 2006:151-9.
68. Greenfield JM, Lucas S, Levine LA. Factors affecting the loss of length associated with tunical albuginea plication for correction of penile curvature. J Urol 2006;175:238-41.
69. Alphs HH, Navai N, Köhler TS, McVary KT. Preoperative clinical and diagnostic characteristics of patients who require delayed IPP after primary Peyronie's repair. J Sex Med 2010;7:1262-8.
70. Levine LA, Greenfield JM, Estrada CR. Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction. J Sex Med 2005;2:241-7.
71. Gelbard MK. Relaxing incisions in the correction of penile deformity due to Peyronie's disease. J Urol 1995;154:1457-60.
72. Egydio PH, Lucon AM, Arap S. A single relaxing incision to correct different types of penile curvature: Surgical technique based on geometrical principles. BJU Int 2004;94:1147-57.
73. Kadioglu A, Sanli O, Akman T, Ersay A, Guven S, Mammadov F. Graft materials in Peyronie's disease surgery: A comprehensive review. J Sex Med 2007;4:581-95.
74. Lowsley OS, Boyce WH. Further experiences with an operation for the cure of Peyronie's disease. J Urol 1950;63:888-902.
75. Devine CJ, Jr, Horton CE. Surgical treatment of Peyronie's disease with a dermal graft. J Urol 1974;111:44-9.
76. Das S. Peyronie's disease: Excision and autografting with tunica vaginalis. J Urol 1980;124:818-9.
77. Sampaio JS, Passarinho FA, Mendes CJ. Peyronie's disease. Surgical correction of 40 patients with relaxing incision and dura mater graft. Eur Urol 2002;41:551-5.
78. Burnett AL. Fascia lata in penile reconstructive surgery: A reappraisal of the fascia lata graft. Plast Reconstr Surg 1997;99:1061-7.
79. Lue TF, El-Sakka AI. Venous patch graft for Peyronie's disease. Part I: Technique. J Urol 1998;160:2047-9.
80. Teloken C, Grazziotin T, Rhoden E, Da Ros C, Fornari A, Soares FC, Souto C. Penile straightening with crural graft of the corpus cavernosum. J Urol 2000;164:107-8.
81. Shioshvili TJ, Kakonashvili AP. The surgical treatment of Peyronie's disease: Replacement of plaque by free autograft of buccal mucosa. Eur Urol 2005;48:129-35.
82. Brannigan RE, Kim ED, Oyasu R, McVary KT. Comparison of tunica albuginea substitutes for the treatment of Peyronie's disease. J Urol 1998;159:1064-8.
83. Hellstrom WJ, Reddy S. Application of pericardial graft in the surgical management of Peyronie's disease. J Urol 2000;163:1445-7.
84. Knoll LD. Use of small intestinal submucosa graft for the surgical management of Peyronie's disease. J Urol 2007;178:2474-8.
85. John T, Bandi G, Santucci R. Porcine small intestinal submucosa is not an ideal graft material for Peyronie's disease surgery. J Urol 2006;176:1025-9.
86. Breyer BN, Brant WO, Garcia MM, Bella AJ, Lue TF. Complications of porcine small intestine submucosa graft for Peyronie's disease. J Urol 2007;177:589-91.
87. Kovac JR, Brock GB. Surgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie's disease. J Sex Med 2007;4:1500-8.
88. Chung E, Clendinning E, Lessard L, Brock G. Five-year follow-up of Peyronie's graft surgery: Outcomes and patient satisfaction. J Sex Med 2011;8:594-600.
89. Levine LA. Partial plaque excision and grafting (PEG) for Peyronie's disease. J Sex Med 2011;8:1842-5.
90. Dalkin BL, Carter MF. Venogenic impotence following dermal graft repair for Peyronie's disease. J Urol 1991;146:849-51.
91. Garaffa G, Sacca A, Christopher AN, Ralph DJ. Circumcision is not mandatory in penile surgery. BJU Int 2010;105:222-4.
92. Horton CE, Sadove RC, Devine CJ. Peyronie's disease. Ann Plast Surg 1987;18:122-7.
93. Moncada-Iribarren I, Jara J, Martinez-Salamanca JI, Cabello R, Hernandez C. Managing penile shortening after Peyronie's Disease Surgery. [Abst 750] Annual Meeting of the American Urological Association. 2007.
94. Levine LA, Rybak J. A comparative analysis of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: Measured lengths and patient perceptions. [Abst 1814] Annual Meeting of the American Urological Association. 2011.
95. Kalsi J, Minhas S, Christopher N, Ralph D. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's Disease. BJU Int 2005;95:1029-33.
96. Montorsi F, Salonia A, Briganti A, Dehò F, Zanni G, Luigi DP, Rigatti P. Five-year follow-up of plaque incision and vein grafting for Peyronie's disease. J Urol 2004;171:331 (abstract no. 1256).
97. Dimitriou R, Levine LA. A surgical algorithm for penile prosthesis placement in men with erectile failure and Peyronie's disease. J Urol 1999;161:1014A.
98. Wilson SK, Delk JR, 2nd. A new treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesis. J Urol 1994;152:1121-3.
99. Montorsi F, Guazzoni G, Bergamaschi F, Rigatti P. Patient-partner satisfaction with semirigid penile prostheses for Peyronie's disease: A 5-year follow-up study. J Urol 1993;150:1819-21.
100. Wilson SK, Cleves MA, Delk JR, 2nd. Long-term follow-up of treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesis. J Urol 2001;165:825-9.
101. Levine LA, Benson JS, Hoover C. Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study. J Sex Med 2010;7:3775-83.
102. Rahman NU, Carrion RE, Bochinski D, Lue TF. Combined penile plication surgery and insertion of penile prosthesis for severe penile curvature and erectile dysfunction. J Urol 2004;171:2346-9.
103. Hakim LS, Kulaksizoglu H, Hamill BK, Udelson D, Goldstein IA. Guide to safe corporotomy incisions in the presence of underlying inflatable penile cylinders: Results of in vitro and in vivo studies. J Urol 1996;155:918-23.
104. Akin-Olugbade O, Parker M, Guhring P, Mulhall J. Determinants of patients satisfaction following penile prosthesis surgery. J Sex Med 2006;3:743-8.
105. Montague DK. Penile prosthesis implantation: Size matters. Eur Urol 2007;51:887-8.
106. Levine LA, Rybak J. Traction therapy for men with shortened penis prior to penile prosthesis implantation: A pilot study. J Sex Med 2011;8:2112-7.